Drug Profile
Research programme: alpha-7 nicotinic acetylcholine receptor modulators - Janssen Pharmaceutica
Alternative Names: JNJ-1930942Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Janssen Pharmaceutica
- Class
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in Belgium
- 21 Oct 2009 Preclinical trials in Cognition disorders in Belgium (unspecified route)